Ogn - osteoglycin Gene
Also Known as OG; OIF; SLRR3A; mimecan; mimican; 3110079A16Rik
Species: Mus musculus
Gene Type: protein coding
Gene ID: 18295
Summary
Predicted to enable growth factor activity. Predicted to be an extracellular matrix structural constituent conferring compression resistance. Predicted to be involved in negative regulation of smooth muscle cell proliferation. Located in collagen-containing extracellular matrix and extracellular space. Is expressed in several structures, including alimentary system; brain; embryo mesenchyme; genitourinary system; and skeleton. Orthologous to human OGN (osteoglycin). [provided by Alliance of Genome Resources, Apr 2022]
Ogn Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_008760.5 | NP_032786.1 | mimecan precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
mimecan |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS09764 | OGN Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18219 | Ogn Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24696 | Ogn Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service